Nimodipine BP(30mg) ... .. .. .

NIMONIDIP 30  

Nimodipine BP(30mg)

NIMONIDIP 30 is a prescription medication that contains Nimodipine BP (30mg) as its active ingredient. Nimodipine is a calcium channel blocker that is primarily used to treat and manage subarachnoid hemorrhage (SAH), a condition often resulting from a ruptured aneurysm. It works by dilating blood vessels, especially in the brain, helping to improve blood flow and reduce the risk of cerebral vasospasm, a life-threatening complication following SAH. NIMONIDIP 30 plays a vital role in preventing neurological damage and improving recovery outcomes in patients with certain cerebrovascular conditions.

Key Features and Ingredients

• Active Ingredient: Nimodipine BP (30mg)
  The active component of NIMONIDIP 30 is Nimodipine, which is a potent calcium channel blocker. It primarily acts on the smooth muscle cells in blood vessels, particularly those in the brain. By inhibiting the influx of calcium ions into these cells, Nimodipine causes the blood vessels to relax and dilate, improving blood flow and reducing the risk of cerebral vasospasm after subarachnoid hemorrhage (SAH). The 30mg dose is often used to provide therapeutic effects while minimizing potential side effects.

• Dosage: 30mg
  NIMONIDIP 30 comes in a 30mg tablet form, typically taken as prescribed by a healthcare professional. The dosage and treatment plan will depend on the patient’s condition and overall response to therapy. Nimodipine is usually administered over a period of time to ensure that the patient receives the full benefit of the medication.

Usage

NIMONIDIP 30 is primarily used for the following conditions:

1. Subarachnoid Hemorrhage (SAH):
   NIMONIDIP 30 is most commonly prescribed to prevent cerebral vasospasm in patients who have experienced a subarachnoid hemorrhage (SAH). This condition, which typically results from a ruptured aneurysm, can lead to a narrowing of blood vessels in the brain, reducing blood flow and oxygen supply to critical areas of the brain. Nimodipine helps to prevent or reduce vasospasm, which can improve recovery and reduce the risk of further brain injury.

2. Cerebral Vasospasm:
   Cerebral vasospasm is a serious condition that can occur after SAH, where the blood vessels in the brain constrict, limiting blood flow and oxygen to the brain. By improving the dilation of blood vessels, NIMONIDIP 30 helps maintain adequate cerebral circulation, promoting better recovery and minimizing the neurological damage caused by this condition.

3. Improvement of Neurological Outcomes:
   In patients with a history of SAH, Nimodipine has been shown to improve neurological outcomes by supporting better blood flow to the brain. NIMONIDIP 30 is used as part of the management strategy for patients recovering from a subarachnoid hemorrhage, aiding in recovery and reducing the likelihood of further complications.

Benefits of NIMONIDIP 30

1. Prevents Cerebral Vasospasm:
   The most significant benefit of NIMONIDIP 30 is its ability to prevent cerebral vasospasm after a subarachnoid hemorrhage. Nimodipine (30mg) works by relaxing the blood vessels in the brain, thus improving blood flow and reducing the risk of vasospasm that can lead to ischemic brain injury and poor recovery outcomes.

2. Improves Neurological Recovery:
   NIMONIDIP 30 is effective in improving the neurological recovery of patients after an SAH. By preventing further constriction of the brain’s blood vessels, it supports the delivery of oxygen and nutrients to brain cells, which aids in the healing process and reduces the chances of long-term neurological deficits.

3. Reduces Risk of Brain Damage:
   The reduction in vasospasm facilitated by NIMONIDIP 30 helps prevent brain damage that can result from insufficient blood supply. Nimodipine (30mg) ensures that the brain receives adequate blood flow, even in the critical recovery phase after SAH, thereby reducing the risk of further complications and improving overall outcomes.

4. Safe and Well-Tolerated:
   NIMONIDIP 30 is generally well-tolerated with a low incidence of side effects when used as directed. While some mild side effects such as dizziness or headache may occur, they are typically short-lived. The medication is designed to work effectively with minimal risk, providing patients with a valuable treatment option for managing their condition.

5. Convenient Oral Formulation:
   NIMONIDIP 30 is available in a convenient oral tablet form, making it easy for patients to take as part of their treatment regimen. This ease of administration helps ensure better patient compliance, which is essential for optimal treatment outcomes.

Key Considerations

• Side Effects:
  While NIMONIDIP 30 is generally safe, some patients may experience mild side effects such as dizziness, nausea, or headache. In rare cases, low blood pressure or bradycardia (slow heart rate) may occur. Patients should discuss any side effects with their healthcare provider to manage them effectively.

• Drug Interactions:
  Nimodipine can interact with certain medications, particularly those affecting blood pressure or other calcium channel blockers. Patients should inform their doctor about all the medications they are taking to avoid any drug interactions that could affect the efficacy or safety of NIMONIDIP 30.

• Not for All Conditions:
  NIMONIDIP 30 is specifically designed for use in the management of subarachnoid hemorrhage and cerebral vasospasm. It is not suitable for treating other conditions unless directed by a healthcare professional. Always use NIMONIDIP 30 according to medical advice to ensure its appropriateness for your condition.

Conclusion

NIMONIDIP 30, with its active ingredient Nimodipine (30mg), is an essential medication for managing the complications of subarachnoid hemorrhage (SAH), particularly in preventing cerebral vasospasm. By improving blood flow and dilating blood vessels in the brain, NIMONIDIP 30 plays a crucial role in improving neurological outcomes and reducing the risk of brain damage following an SAH. Its easy-to-administer oral formulation, combined with its significant therapeutic effects, makes it a vital treatment option for patients recovering from subarachnoid hemorrhage. However, as with any medication, it’s essential to follow the prescribed dosage and consult a healthcare provider about potential side effects or interactions. Always use NIMONIDIP 30 under medical supervision for the best possible results. Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options. The company offers a wide range of healthcare products, catering to various medical needs, from rare disease treatments to essential healthcare products. Sterispharma's product range includes solutions for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medicines can be conveniently ordered via Our websites—Sterisonline, Sterisindia, and Sterispharma.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW